StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) stock

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$1.98+0.04 (+2.06%)

Close on Nov 12, 2026Market cap $78.11MP/E –Yield –

Sera Prognostics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Sera Prognostics's profit margin for the twelve months ending Sep 30, 2026 was -34866.7%. For fiscal 2025 it was -39417.3%, against -42724.7% the year before. The highest annual figure on record is -11843.8% in fiscal 2023.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-39417.3%+3307.4
FY2024Dec 31, 2024-42724.7%−30880.9
FY2023Dec 31, 2023-11843.8%+4643.5
FY2022Dec 31, 2022-16487.3%+26206.6
FY2021Dec 31, 2021-42693.9%+36698.1
FY2020Dec 31, 2020-79392.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-19173.8%+29663.7
Q2 FY2026Jun 30, 2026-30463.3%+16866.1
Q1 FY2026Mar 31, 2026-59992.9%−38448.1
Q4 FY2025Dec 31, 2025-78810.0%−43064.2
Q3 FY2025Sep 30, 2025-48837.5%−21530.6
Q2 FY2025Jun 30, 2025-47329.4%−12733.6
Q1 FY2025Mar 31, 2025-21544.7%−2215.5
Q4 FY2024Dec 31, 2024-35745.8%−18579.2
Q3 FY2024Sep 30, 2024-27306.9%−18736.2
Q2 FY2024Jun 30, 2024-34595.8%−24030.8
Q4 FY2023Dec 31, 2023-19329.3%−4335.4
Q3 FY2023Sep 30, 2023-17166.7%−4854.0
Q2 FY2023Jun 30, 2023-8570.7%+6198.5
Q1 FY2023Mar 31, 2023-10565.0%+21561.3
Q4 FY2022Dec 31, 2022-14993.8%+33021.5
Q3 FY2022Sep 30, 2022-12312.6%+30552.6
Q2 FY2022Jun 30, 2022-14769.2%+16765.8
Q1 FY2022Mar 31, 2022-32126.3%+16789.1
Q4 FY2021Dec 31, 2021-48015.4%+41567.9
Q3 FY2021Sep 30, 2021-42865.2%+58574.8
Q2 FY2021Jun 30, 2021-31535.0%+46881.7
Q1 FY2021Mar 31, 2021-48915.4%–
Q4 FY2020Dec 31, 2020-89583.3%–
Q3 FY2020Sep 30, 2020-101440.0%–
Q2 FY2020Jun 30, 2020-78416.7%–

More Sera Prognostics figures

See a number that looks wrong?